Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 496

1.

Low-dose doxepin for the treatment of insomnia: emerging data.

Goforth HW.

Expert Opin Pharmacother. 2009 Jul;10(10):1649-55. doi: 10.1517/14656560903005587. Review.

PMID:
19496739
[PubMed - indexed for MEDLINE]
2.

Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study.

Hajak G, Rodenbeck A, Voderholzer U, Riemann D, Cohrs S, Hohagen F, Berger M, Rüther E.

J Clin Psychiatry. 2001 Jun;62(6):453-63.

PMID:
11465523
[PubMed - indexed for MEDLINE]
3.

Novel therapeutic usage of low-dose doxepin hydrochloride.

Singh H, Becker PM.

Expert Opin Investig Drugs. 2007 Aug;16(8):1295-305. Review.

PMID:
17685877
[PubMed - indexed for MEDLINE]
4.

Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study.

Scharf M, Rogowski R, Hull S, Cohn M, Mayleben D, Feldman N, Ereshefsky L, Lankford A, Roth T.

J Clin Psychiatry. 2008 Oct;69(10):1557-64. Epub 2008 Oct 7.

PMID:
19192438
[PubMed - indexed for MEDLINE]
5.

Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.

Krystal AD, Durrence HH, Scharf M, Jochelson P, Rogowski R, Ludington E, Roth T.

Sleep. 2010 Nov;33(11):1553-61.

PMID:
21102997
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia.

Hajak G, Rodenbeck A, Adler L, Huether G, Bandelow B, Herrendorf G, Staedt J, Rüther E.

Pharmacopsychiatry. 1996 Sep;29(5):187-92.

PMID:
8895944
[PubMed - indexed for MEDLINE]
7.

Low-dose doxepin: in the treatment of insomnia.

Weber J, Siddiqui MA, Wagstaff AJ, McCormack PL.

CNS Drugs. 2010 Aug;24(8):713-20. doi: 10.2165/11200810-000000000-00000. Review.

PMID:
20658801
[PubMed - indexed for MEDLINE]
8.

The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks.

Rodenbeck A, Cohrs S, Jordan W, Huether G, Rüther E, Hajak G.

Psychopharmacology (Berl). 2003 Dec;170(4):423-8. Epub 2003 Sep 10.

PMID:
13680082
[PubMed - indexed for MEDLINE]
9.

Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia.

Roth T, Rogowski R, Hull S, Schwartz H, Koshorek G, Corser B, Seiden D, Lankford A.

Sleep. 2007 Nov;30(11):1555-61.

PMID:
18041488
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.

Riemann D, Voderholzer U, Cohrs S, Rodenbeck A, Hajak G, Rüther E, Wiegand MH, Laakmann G, Baghai T, Fischer W, Hoffmann M, Hohagen F, Mayer G, Berger M.

Pharmacopsychiatry. 2002 Sep;35(5):165-74.

PMID:
12237787
[PubMed - indexed for MEDLINE]
11.

Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.

Krystal AD, Lankford A, Durrence HH, Ludington E, Jochelson P, Rogowski R, Roth T.

Sleep. 2011 Oct 1;34(10):1433-42. doi: 10.5665/SLEEP.1294.

PMID:
21966075
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Selective histamine H(1) antagonism: a novel approach to insomnia using low-dose doxepin.

Owen RT.

Drugs Today (Barc). 2009 Apr;45(4):261-7. doi: 10.1358/dot.2009.45.4.1358835.

PMID:
19499091
[PubMed - indexed for MEDLINE]
13.

Histamine-1 receptor antagonism for treatment of insomnia.

Vande Griend JP, Anderson SL.

J Am Pharm Assoc (2003). 2012;52(6):e210-9. doi: 10.1331/JAPhA.2012.12051. Review.

PMID:
23229983
[PubMed - indexed for MEDLINE]
14.

Low-dose doxepin (Silenor) for insomnia.

[No authors listed]

Med Lett Drugs Ther. 2010 Oct 4;52(1348):79-80. Review. No abstract available.

PMID:
20885342
[PubMed - indexed for MEDLINE]
15.

Paroxetine in the treatment of primary insomnia: preliminary clinical and electroencephalogram sleep data.

Nowell PD, Reynolds CF 3rd, Buysse DJ, Dew MA, Kupfer DJ.

J Clin Psychiatry. 1999 Feb;60(2):89-95.

PMID:
10084634
[PubMed - indexed for MEDLINE]
16.

The effects of doxepin HCl on sleep and depression.

Roth T, Zorick F, Wittig R, McLenaghan A, Roehrs T.

J Clin Psychiatry. 1982 Sep;43(9):366-8.

PMID:
7118845
[PubMed - indexed for MEDLINE]
17.

Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia.

Lankford A, Rogowski R, Essink B, Ludington E, Heith Durrence H, Roth T.

Sleep Med. 2012 Feb;13(2):133-8. doi: 10.1016/j.sleep.2011.09.006. Epub 2011 Dec 24.

PMID:
22197474
[PubMed - indexed for MEDLINE]
18.

Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies.

Rosenberg RP.

Ann Clin Psychiatry. 2006 Jan-Mar;18(1):49-56. Review.

PMID:
16517453
[PubMed - indexed for MEDLINE]
19.

Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease -- a randomized study.

Rios Romenets S, Creti L, Fichten C, Bailes S, Libman E, Pelletier A, Postuma RB.

Parkinsonism Relat Disord. 2013 Jul;19(7):670-5. doi: 10.1016/j.parkreldis.2013.03.003. Epub 2013 Apr 2.

PMID:
23561946
[PubMed - indexed for MEDLINE]
20.

Efficacy and safety of doxepin 6 mg in a model of transient insomnia.

Roth T, Heith Durrence H, Jochelson P, Peterson G, Ludington E, Rogowski R, Scharf M, Lankford A.

Sleep Med. 2010 Oct;11(9):843-7. doi: 10.1016/j.sleep.2010.07.006.

PMID:
20817598
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk